Further evidence to demonstrate the significance of serum appearance of anti-p53 antibody as a marker for progressive potential in invasive ductal carcinoma of the breast-Reference-Cited by-同舟云学术

Further evidence to demonstrate the significance of serum appearance of anti-p53 antibody as a marker for progressive potential in invasive ductal carcinoma of the breast

Published:2017 Issue:3.4 Volume:64 Page:241-244
ISSN:1343-1420
Container-title:The Journal of Medical Investigation
language:en
Short-container-title:J. Med. Invest.

Author:

Nozoe Tadahiro¹,Nozoe Emiko²,Kono Mayuko¹,Ohga Takefumi¹,Ezaki Takahiro¹

Affiliation:

1. Department of Surgery, Fukuoka Higashi Medical Center

2. Department of Breast Surgery, Saiseikai Fukuoka General Hospital

Publisher

University of Tokushima Faculty of Medicine

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.jstage.jst.go.jp/article/jmi/64/3.4/64_241/_pdf

Reference20 articles.

1. 1. Forslund A, Kressner U, Lindmark G, Inganäs M, Lundholm K: Serum anti-p53 in relation to mutations across the entire translated p53 gene in colorectal carcinomas. Int J Oncol 19: 501-506, 2001

2. 2. Nozoe T, Mori E, Kono M, Iguchi T, Maeda T, Matsukuma A, Ezaki T: Serum appearance of anti-p53 antibody in triple negative breast cancer. Breast Cancer 19: 11-15, 2012

3. 3. Yamamoto S, Chishima T, Adachi S, Harada F, Toda Y, Arioka H, Hasegawa N, Kakuta Y: Serum p53 antibody in breast cancer. Cancer Biomark 14: 203-208, 2014

4. 4. Nozoe T, Mori E, Iguchi T, Ezaki T: New criteria to predict tumor recurrence in invasive ductal carcinoma of the breast. Int Surg 98: 283-288, 2013

5. 5. Japanese breast cancer society: General rules for clinical and pathological recording of breast cancer. Breast Cancer 12: S12-14, 2005

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NOTCH3 T6746C and TP53 P72R Polymorphisms Are Associated with the Susceptibility to Diffuse Cutaneous Systemic Sclerosis;BioMed Research International;2020-02-25

2. Uselessness of Serum p53 Antibody for Detecting Colitis-associated Cancer in the Era of Immunosuppressive Therapy;In Vivo;2020